Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02067286 · ClinicalTrials.gov registry record
Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer
A clinical trial of Respiratory Syncytial Virus (RSV) and Influenza a, sponsored by IQuum.
- Completed
- Registry status
- 1,642
- Enrollment target
- 8
- Study locations
NCT02067286: Completed study of Respiratory Syncytial Virus (RSV) and Influenza a, sponsored by IQuum.
NCT02067286 is a study of Respiratory Syncytial Virus (RSV) and Influenza a that has completed, run by IQuum. The registered enrollment target is 1,642 participants, below the 6,607-participant average among 11 other Respiratory Syncytial Virus (RSV) trials with a reported enrollment target (75% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02067286, a study of Respiratory Syncytial Virus (RSV) and Influenza a, has completed, sponsored by IQuum.
- COMPLETED
- Registry status
- 1,642 participants
- Enrollment target
- 8
- Study locations
Study Summary
The objective of this study is to evaluate the clinical sensitivity and specificity of the Liat™ Influenza A/B \& RSV Assay and the Liat™ Influenza A/B Assay when used on the Liat Analyzer to detect the presence or absence of Influenza A, Influenza B, and RSV in a nasopharyngeal swab specimen as compared to an FDA approved NAAT and culture.
Conditions Studied
Study Locations (8)
Texas
- Accurate Clinical Research - Houston
- Plano Pediatrics - Plano
Florida
- Pediatrics-by-the-Sea - Delray Beach
Georgia
- Meridian Clinical Research - Savannah
Indiana
- Northpoint Pediatrics - Indianapolis
Nebraska
- Meridian Clinical Research - Bellevue
Ohio
- Cleveland Clinic - Cleveland
Virginia
- Advanced Pediatrics - Vienna
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,642 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-04 |
What the finished NCT02067286 record still lists
NCT02067286 is an observational study that tracks outcomes without assigning an intervention. Its 1,642 participants enrollment target places it among the larger protocols in the corpus, below the 6,607-participant average among 11 other Respiratory Syncytial Virus (RSV) trials with a reported enrollment target (75% lower).
The record links to 3 conditions, with Respiratory Syncytial Virus (RSV) appearing as the primary indexed condition, and to 0 interventions.
NCT02067286 lists 8 locations in 7 states (Texas, Florida, Georgia).
Frequently Asked Questions
What is clinical trial NCT02067286 about?
NCT02067286 is a clinical study titled "Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer". The objective of this study is to evaluate the clinical sensitivity and specificity of the Liat™ Influenza A/B \& RSV Assay and the Liat™ Influenza A/B Assay when used on the Liat Analyzer to detect the presence or absence of Influenza A, Influenza B, and RSV in a nasopharyngeal swab specimen as com...
What is the current status of trial NCT02067286?
This trial is currently completed. The enrollment target is 1,642 participants. The study started on 2014-01. Estimated completion is 2015-04.
What conditions does trial NCT02067286 study?
This clinical trial studies the following conditions: Respiratory Syncytial Virus (RSV), Influenza a, Influenza B.
Who is sponsoring clinical trial NCT02067286?
This trial is sponsored by IQuum, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02067286 being conducted?
This trial has 8 study locations across Florida, Georgia, Indiana, Nebraska, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Syncytial Virus (RSV)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02067286's enrollment target sits among peer trials
1,642 5th of 11 higher than 7 of 11 other Respiratory Syncytial Virus (RSV) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Respiratory Syncytial Virus (RSV) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
RSV Vaccine Pregnancy Registry
RECRUITING
-
Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons
RECRUITING · Phase 2
-
Systems Biological Analysis of Immune Responses to RSV Vaccine
ACTIVE NOT RECRUITING · Phase 4
-
A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
ACTIVE NOT RECRUITING · Phase 1
-
Transplacental Transmission of RSV (TTRSV)
ACTIVE NOT RECRUITING
-
Evaluating ABRYSVO Maternal Vaccine Effectiveness Among Infants
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04510129 · 1,650 participants
A Multicenter Cancer Biospecimen Collection Study
- NCT05612750 · 1,650 participants · NA
Comparative Effectiveness of Online 8-session CBT vs. 1-Session Empowered Relief for Chronic Pain - The PROGRESS Study
- NCT06215716 · 1,650 participants · Phase 3
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- NCT07046260 · 1,650 participants
Prospective Study to Assess a Diagnostic Aid for Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia